Literature DB >> 21034368

Understanding XDP through imaging, pathology, and genetics.

Paul Matthew D Pasco1, Claro V Ison, Edwin L Muňoz, Nelma S Magpusao, Anthony E Cheng, Kenneth T Tan, Raymundo W Lo, Rosalia A Teleg, Marita B Dantes, Ruth Borres, Elma Maranon, Cynthia Demaisip, Marita V T Reyes, Lillian V Lee.   

Abstract

The X-linked dystonia-parkinsonism (XDP) is a severe, progressive, adult-onset, X-linked endemic disorder in Filipinos, which is characterized by dystonic movements that start in the third or fourth decade, and replaced by parkinsonism beyond the 10th year of illness. Understanding the pathophysiology of XDP and development of rational therapies will depend on observations from imaging, pathological, and genetic studies. In this paper we summarize the results of these studies on patients with XDP. The cranial magnetic resonance imaging shows hyperintense putaminal rim in both dystonic and parkinsonian stages, and atrophy of the caudate head or putamen in the parkinsonian stage. Neuropathological findings show atrophy of the caudate nucleus and putamen, with mild to severe neuronal loss and gliosis. In the neostriatum, the dystonic phase of XDP shows the involvement of striosomes and matrix sparing, while the later, i.e., parkinsonian phase, shows matrix involvement as well. In the dystonic phase, the loss of striosomal inhibitory projections lead to disinhibition of nigral dopaminergic neurons, perhaps resulting in a hyperkinetic state; while in the parkinsonian phase, severe and critical reduction of matrix-based projection may result in extranigral parkinsonism. Genetic sequencing of the XDP critical region in Xq13.1 has revealed an SVA retrotransposon insertion in an intron of TAF1. This may reduce neuron-specific expression of the TAF1 isoform in the caudate nucleus, and subsequently interfere with the transcription of many neuronal genes, including DRD2. Findings from imaging, pathology, and genetics studies are gradually shedding light on the pathophysiology of XDP, which hopefully will lead to more rational and directed therapies.

Entities:  

Mesh:

Year:  2010        PMID: 21034368     DOI: 10.3109/00207454.2010.526729

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  9 in total

1.  X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B.

Authors:  Christine A Vaine; David Shin; Christina Liu; William T Hendriks; Jyotsna Dhakal; Kyle Shin; Nutan Sharma; D Cristopher Bragg
Journal:  Neurobiol Dis       Date:  2016-12-22       Impact factor: 5.996

2.  JPH3 repeat expansions cause a progressive akinetic-rigid syndrome with severe dementia and putaminal rim in a five-generation African-American family.

Authors:  Susanne A Schneider; Kate E Marshall; Jianfeng Xiao; Mark S LeDoux
Journal:  Neurogenetics       Date:  2012-03-25       Impact factor: 2.660

3.  Evidence of TAF1 dysfunction in peripheral models of X-linked dystonia-parkinsonism.

Authors:  Aloysius Domingo; David Amar; Karen Grütz; Lillian V Lee; Raymond Rosales; Norbert Brüggemann; Roland Dominic Jamora; Eva Cutiongco-Dela Paz; Arndt Rolfs; Dirk Dressler; Uwe Walter; Dimitri Krainc; Katja Lohmann; Ron Shamir; Christine Klein; Ana Westenberger
Journal:  Cell Mol Life Sci       Date:  2016-02-15       Impact factor: 9.261

4.  Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity.

Authors:  Hanyin Cheng; Simona Capponi; Emma Wakeling; Elaine Marchi; Quan Li; Mengge Zhao; Chunhua Weng; Piatek G Stefan; Helena Ahlfors; Robert Kleyner; Alan Rope; Aimé Lumaka; Prosper Lukusa; Koenraad Devriendt; Joris Vermeesch; Jennifer E Posey; Elizabeth E Palmer; Lucinda Murray; Eyby Leon; Jullianne Diaz; Lisa Worgan; Amalia Mallawaarachchi; Julie Vogt; Sonja A de Munnik; Lauren Dreyer; Gareth Baynam; Lisa Ewans; Zornitza Stark; Sebastian Lunke; Ana R Gonçalves; Gabriela Soares; Jorge Oliveira; Emily Fassi; Marcia Willing; Jeff L Waugh; Laurence Faivre; Jean-Baptiste Riviere; Sebastien Moutton; Shehla Mohammed; Katelyn Payne; Laurence Walsh; Amber Begtrup; Maria J Guillen Sacoto; Ganka Douglas; Nora Alexander; Michael F Buckley; Paul R Mark; Lesley C Adès; Sarah A Sandaradura; James R Lupski; Tony Roscioli; Pankaj B Agrawal; Antonie D Kline; Kai Wang; H T Marc Timmers; Gholson J Lyon
Journal:  Hum Mutat       Date:  2019-10-23       Impact factor: 4.878

Review 5.  X-linked dystonia parkinsonism: clinical phenotype, genetics and therapeutics.

Authors:  Raymond L Rosales
Journal:  J Mov Disord       Date:  2010-10-30

Review 6.  Clinicopathological Phenotype and Genetics of X-Linked Dystonia-Parkinsonism (XDP; DYT3; Lubag).

Authors:  Toshitaka Kawarai; Ryoma Morigaki; Ryuji Kaji; Satoshi Goto
Journal:  Brain Sci       Date:  2017-06-26

7.  Promise and challenges of dystonia brain banking: establishing a human tissue repository for studies of X-Linked Dystonia-Parkinsonism.

Authors:  Cara Fernandez-Cerado; G Paul Legarda; M Salvie Velasco-Andrada; Abegail Aguil; Niecy G Ganza-Bautista; J Benedict B Lagarde; Jasmin Soria; Roland Dominic G Jamora; Patrick J Acuña; Charles Vanderburg; Ellen Sapp; Marian DiFiglia; Micaela G Murcar; Lindsey Campion; Laurie J Ozelius; Amy K Alessi; Malvindar K Singh-Bains; Henry J Waldvogel; Richard L M Faull; Regina Macalintal-Canlas; Edwin L Muñoz; Ellen B Penney; Mark A Ang; Cid Czarina E Diesta; D Cristopher Bragg; Geraldine Acuña-Sunshine
Journal:  J Neural Transm (Vienna)       Date:  2021-01-13       Impact factor: 3.575

8.  Transcriptional Alterations in X-Linked Dystonia-Parkinsonism Caused by the SVA Retrotransposon.

Authors:  Jelena Pozojevic; Shela Marie Algodon; Joseph Neos Cruz; Joanne Trinh; Norbert Brüggemann; Joshua Laß; Karen Grütz; Susen Schaake; Ronnie Tse; Veronica Yumiceba; Nathalie Kruse; Kristin Schulz; Varun K A Sreenivasan; Raymond L Rosales; Roland Dominic G Jamora; Cid Czarina E Diesta; Jakob Matschke; Markus Glatzel; Philip Seibler; Kristian Händler; Aleksandar Rakovic; Henriette Kirchner; Malte Spielmann; Frank J Kaiser; Christine Klein; Ana Westenberger
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 5.923

Review 9.  Combined dystonias: clinical and genetic updates.

Authors:  Anne Weissbach; Gerard Saranza; Aloysius Domingo
Journal:  J Neural Transm (Vienna)       Date:  2020-10-24       Impact factor: 3.575

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.